Nanologica
0.39 SEK
+0.51 %
Less than 1K followers
NICA
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Quarter data
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Nanologica
| Q3/24 | Q4/24 | 2024 | Q1/25 | Q2/25 | Q3/25 | Q4/25 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.6 | 6.7 | 14.5 | 10.8 | 2.3 | 2.8 | 5.2 | 21.1 |
| EBITDA | -17.0 | -8.1 | -43.7 | -5.6 | -7.6 | -8.0 | -13.2 | -34.4 |
| EBIT | -22.2 | -11.9 | -59.3 | -9.2 | -10.8 | -10.0 | -15.7 | -46.8 |
| EBIT-% | -3,639.3 % | -177.1 % | -407.6 % | -86.0 % | -459.8 % | -352.3 % | -301.7 % | -221.5 % |
| Profit before taxes | -23.7 | -14.0 | -65.6 | -10.2 | -12.3 | -11.0 | -16.7 | -51.3 |
| Net income | -23.7 | -14.0 | -65.6 | -10.2 | -12.3 | -11.0 | -16.7 | -51.3 |